InsiderDB

United Therapeutics (UTHR)

Healthcare · Biotechnology

2 members of Congress have disclosed 6 trades in United Therapeutics (UTHR) since 2023: 2 buys and 4 sales. The most recent was disclosed on Nov 21, 2025.

Trades disclosed
6
Members trading
2
Buys / sells
2 / 4
Reported value
$119K–$360K

Keep following the company.

Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.

Follow UTHR

What else is happening at UTHR

All research →

Company filings and public records connected to this stock, ordered by when they became public or were first observed.

  1. UTHRLobbying report·Lobbying disclosures

    UTHR: third_quarter 2026 lobbying report

    Issues related to organs and xenotransplantation.

    Public: Oct 20, 2026, 1:31 AM EDTOriginal source ↗
  2. UTHRLobbying report·Lobbying disclosures

    UTHR: second_quarter 2026 lobbying report

    Issues related to organs and xenotransplantation.

    Public: Jul 19, 2026, 5:22 PM EDTOriginal source ↗

Who traded UTHR

All trades

From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.